Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Zinner, Ralph
Item TypeName
Concept Adenocarcinoma
Concept Age Factors
Concept Antibodies, Monoclonal
Concept Antibodies, Neoplasm
Concept Antimetabolites, Antineoplastic
Concept Aphonia
Concept Carcinoma, Squamous Cell
Concept Cell Division
Concept Uterine Cervical Neoplasms
Concept Child, Preschool
Concept Clinical Trials as Topic
Concept Cyclohexanes
Concept Decision Making
Concept Demography
Concept Drug Eruptions
Concept Dexamethasone
Concept DNA, Neoplasm
Concept Double-Blind Method
Concept Drug Synergism
Concept Esophageal Neoplasms
Concept Esophagogastric Junction
Concept Amifostine
Concept Etoposide
Concept Feasibility Studies
Concept Folic Acid
Concept Follow-Up Studies
Concept Formaldehyde
Concept Genital Neoplasms, Female
Concept Glucosidases
Concept Glutamates
Concept Guanine
Concept Hospices
Concept Humans
Concept Immunoenzyme Techniques
Concept Immunohistochemistry
Concept Intestinal Neoplasms
Concept Liposomes
Concept Melanoma
Concept Mesenchymoma
Concept Mesothelioma
Concept Metabolic Clearance Rate
Concept Metalloporphyrins
Concept Molecular Weight
Concept Neoplasms, Experimental
Concept Ovarian Neoplasms
Concept Palliative Care
Concept Patient Participation
Concept Peptide Synthases
Concept Phenylurea Compounds
Concept Prostatic Neoplasms
Concept Receptors, Androgen
Concept Receptor, Epidermal Growth Factor
Concept Referral and Consultation
Concept Retrospective Studies
Concept Sesquiterpenes
Concept Stomach Neoplasms
Concept Uterine Neoplasms
Concept Vinblastine
Concept Vitamin B 12
Concept Vocal Cord Paralysis
Concept Colorectal Neoplasms
Concept Reproducibility of Results
Concept Genetic Therapy
Concept Multicenter Studies as Topic
Concept Survival Rate
Concept Single-Blind Method
Concept Proto-Oncogene Proteins p21(ras)
Concept Paclitaxel
Concept Clinical Trials, Phase I as Topic
Concept In Situ Hybridization, Fluorescence
Concept Receptors, Fibroblast Growth Factor
Concept Radiation Pneumonitis
Concept Karnofsky Performance Status
Concept Neuroectodermal Tumors
Concept Receptors, Neuropeptide
Concept Carcinoma, Ductal, Breast
Concept Carcinoma, Lobular
Concept Cholangiocarcinoma
Concept Risk Assessment
Concept ras Proteins
Concept Receptor, ErbB-2
Concept Genes, erbB-2
Concept Genes, erbB-1
Concept Dietary Supplements
Concept Proto-Oncogene Proteins c-met
Concept Cyclin B
Concept Angiogenesis Inhibitors
Concept Receptor Protein-Tyrosine Kinases
Concept MAP Kinase Kinase Kinases
Concept RNA, Small Interfering
Concept Receptors, Vascular Endothelial Growth Factor
Concept Vascular Endothelial Growth Factor A
Concept Taxoids
Concept Ubiquitin-Protein Ligases
Concept MAP Kinase Kinase 1
Concept Proto-Oncogene Proteins B-raf
Concept Cell Proliferation
Concept Proto-Oncogene Proteins c-akt
Concept PTEN Phosphohydrolase
Concept Farnesyltranstransferase
Concept Cyclin B1
Concept Pathology, Molecular
Concept Precision Medicine
Concept TOR Serine-Threonine Kinases
Concept Reduced Folate Carrier Protein
Concept Antibodies, Monoclonal, Humanized
Academic Article Fingerprinting the circulating repertoire of antibodies from cancer patients.
Academic Article Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC).
Academic Article Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.
Academic Article Combining erlotinib and cetuximab is associated with activity in patients with non-small cell lung cancer (including squamous cell carcinomas) and wild-type EGFR or resistant mutations.
Academic Article Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
Academic Article Exploratory study of carboplatin plus the copper-lowering agent trientine in patients with advanced malignancies.
Academic Article Non-small cell lung cancer clinical trials with trastuzumab: their foundation and preliminary results.
Academic Article Short-term restaging of patients with non-small cell lung cancer receiving chemotherapy.
Academic Article MET aberrations and c-MET inhibitors in patients with gastric and esophageal cancers in a phase I unit.
Academic Article Analysis of MET genetic aberrations in patients with breast cancer at MD Anderson Phase I unit.
Academic Article Outcomes of patients with advanced cancer and KRAS mutations in phase I clinical trials.
Academic Article Synergy between VEGF/VEGFR inhibitors and chemotherapy agents in the phase I clinic.
Academic Article A phase I trial of combination trastuzumab, lapatinib, and bevacizumab in patients with advanced cancer.
Academic Article Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.
Academic Article Dual antiangiogenic inhibition: a phase I dose escalation and expansion trial targeting VEGF-A and VEGFR in patients with advanced solid tumors.
Academic Article PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
Academic Article Prostate-specific antitumor activity by probasin promoter-directed p202 expression.
Academic Article Mutation profiling in cholangiocarcinoma: prognostic and therapeutic implications.
Academic Article Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease.
Academic Article Clinical and pharmacokinetic study of TNP-470, an angiogenesis inhibitor, in combination with paclitaxel and carboplatin in patients with solid tumors.
Academic Article STUMP un"stumped": anti-tumor response to anaplastic lymphoma kinase (ALK) inhibitor based targeted therapy in uterine inflammatory myofibroblastic tumor with myxoid features harboring DCTN1-ALK fusion.
Academic Article Pemetrexed clinical studies in performance status 2 patients with non-small cell lung cancer (Review).
Academic Article Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.
Academic Article Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience.
Academic Article BRAF Mutation Testing in Cell-Free DNA from the Plasma of Patients with Advanced Cancers Using a Rapid, Automated Molecular Diagnostics System.
Academic Article Dual EGFR inhibition in combination with anti-VEGF treatment: a phase I clinical trial in non-small cell lung cancer.
Academic Article Actionable mutations in plasma cell-free DNA in patients with advanced cancers referred for experimental targeted therapies.
Academic Article Activity of c-Met/ALK Inhibitor Crizotinib and Multi-Kinase VEGF Inhibitor Pazopanib in Metastatic Gastrointestinal Neuroectodermal Tumor Harboring EWSR1-CREB1 Fusion.
Academic Article The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
Academic Article The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
Academic Article Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Academic Article The VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers.
Concept Cetuximab
Concept Cdc20 Proteins
Concept Trastuzumab
Concept Bevacizumab
Concept Pemetrexed
Academic Article Dose-escalation study of vemurafenib with sorafenib or crizotinib in patients with BRAF-mutated advanced cancers.
Academic Article S6K1 blockade overcomes acquired resistance to EGFR-TKIs in non-small cell lung cancer.
Search Criteria
  • Receptor
  • ErbB
  • 4